Genesys Capital invests in and builds companies in the high-growth sectors of life sciences. We have a proven track record of identifying emerging bioscience opportunities, and transforming them into commercially successful companies.
Employees: 1-10
Portfolio 21
| Date | Name | Website | Total Raised | Location |
| 27.10.2023 | Cryostasis... | cryostasis... | - | - |
| 27.10.2023 | giiant pha... | giiant.com | $11M | Canada, Mo... |
| 30.01.2022 | Questat In... | questat.ca | - | - |
| 30.01.2022 | Veralox Th... | veralox.co... | $22M | - |
| - | Inversago ... | inversago.... | $137M | - |
| - | Ionalytics... | thermo.com | - | United Sta... |
| - | Debiopharm | debiopharm... | - | Switzerlan... |
| - | Adapsyn Bi... | adapsyn.co... | - | - |
| - | Novadaq | novadaq.co... | - | Canada, On... |
| - | Fusion Pha... | fusionphar... | $195.91M | Canada, On... |
Show more
Mentions in press and media 6
| Date | Title | Description | Source |
| 06.03.2020 | Aortyx cierra una ronda de €650.000 liderada por Genesis Ven... | 06/03/2020 Nota de prensa AORTYX CIERRA UNA RONDA DE €650.000 LIDERADA POR GENESIS VENTURES. Aort... | webcapital... |
| 24.08.2016 | Genesys Capital closes $90 million of its $125 million targe... | Toronto-based Genesys Capital, which is focused on investing in seed healthcare startups, announced ... | betakit.co... |
| 17.12.2012 | Naurex Raises $38M in Series B Financing | Naurex Inc., an Evanston, Illinois-based clinical-stage company focused on psychiatry and neurology,... | finsmes.co... |
| - | Fusion Pharmaceuticals Raises $105 Million In Oversubscribed... | Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-parti... | healthcap.... |
| - | Fusion Pharmaceuticals Completes Oversubscribed Series A Fin... | HAMILTON, ONTARIO, September 25, 2017 – Fusion Pharmaceuticals, a clinical-stage biopharmaceutical c... | healthcap.... |
| - | Fusion Pharmaceuticals Launches with a $25M USD Series A Fin... | HAMILTON ONTARIO, February 23, 2017 – Fusion Pharmaceuticals, a newly formed biopharmaceutical compa... | healthcap.... |